Apronal
Chemical compound
Apronal (brand name Sedormid), or apronalide, also known as allylisopropylacetylurea or allylisopropylacetylcarbamide, is a hypnotic/sedative drug of the ureide (acylurea) group synthesized in 1926 by Hoffmann-La Roche. Though it is not a barbiturate, apronal is similar in structure to the barbiturates (being an open-chain carbamide instead of having a heterocyclic ring).
Nº Q1095009 ★★
Uncommon · Knowledge
Apronal
Chemical compound
Apronal (brand name Sedormid), or apronalide, also known as allylisopropylacetylurea or allylisopropylacetylcarbamide, is a hypnotic/sedative drug of the ureide (acylurea) group synthesized in 1926 by Hoffmann-La Roche. Though it is not a barbiturate, apronal is similar in structure to the barbiturates (being an open-chain carbamide instead of having a heterocyclic ring).
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
Apronal (brand name Sedormid), or apronalide, also known as allylisopropylacetylurea or allylisopropylacetylcarbamide, is a hypnotic/sedative drug of the ureide (acylurea) group synthesized in 1926 by Hoffmann-La Roche. Though it is not a barbiturate, apronal is similar in structure to the barbiturates (being an open-chain carbamide instead of having a heterocyclic ring). In accordance, it is similar in action to the barbiturates, although considerably milder in comparison (formerly used as a daytime sedative at doses of 1 to 2 grams every 3 to 4 hours). Upon the finding that it caused patients to develop thrombocytopenic purpura, apronal was withdrawn from clinical use. Medicines with apronal are no longer used except in Japan and South Korea. The Therapeutic Goods Administration issued a safety alert in May 2023 which prohibits the sale, supply and use of Japanese EVE-branded products in Australia due to its dangerous side effects.
Text: Wikipédia, CC BY-SA 4.0. · Image: Fvasconcellos 02:48, 23 August 2007 (UTC) (Public domain) ·
Related cards
-
Clomethiazole
Sedative and anti-hypnotic medication
Nº Q417178 ★★★
Not listed
-
Paracetamol
Chemical compound with antipyretic and pain relieving properties
Nº Q57055 ★★★★★
Not listed
-
Carfentanil
Chemical compound
Nº Q423386 ★★★
Not listed
-
Barbiturate
Class of compounds
Nº Q206348 ★★★★★
Not listed
-
Piperonal
Chemical compound
Nº Q418985 ★★★
Not listed
-
Mepacrine
Chemical compound
Nº Q417208 ★
Not listed